Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Collantes Estevez

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Rheumatology|June 26, 1998
Osteonecrosis of the tibial plateauP Carpintero-Benitez, E Collantes-Estevez
The Journal of Rheumatology|June 1, 1996
Enthesopathy in leprosyP Carpintero-Benítez, C Logroño, E Collantes-Estevez
The Journal of Rheumatology|February 1, 1995
Assessment of 2 systems of spondyloarthropathy diagnostic and classification criteria (Amor and ESSG) by a Spanish multicenter study. European Spondyloarthropathy Study GroupE Collantes-Estevez, A Cisnal del Mazo, E Muñoz-Gomariz
Clinical and Experimental Rheumatology|January 1, 1993
Expression of complement receptors (CR1 and CR3) and Fc gamma RIII on polymorphonuclears from patients with spondylarthropathiesA Kahan, E Collantes-Estevez, M Barel, et al.
Clinical Rheumatology|March 1, 1990
Hyperuricemia-hyperlipemia association in the absence of obesity and alcohol abuseE Collantes Estevez, M Pineda Priego, J Añon Barbudo, et al.
Scandinavian Journal of Rheumatology|January 15, 2008
The cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in Spain. Comparison of clinical trial and clinical practice dataG Kobelt, P Sobocki, J Mulero, et al.
Annals of the Rheumatic Diseases|October 17, 2002
Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experienceJ Braun, J Sieper, M Breban, et al.
Joint Bone Spine|December 13, 2002
Distribution of HLA-DRB1 genes in patients with sporadic ankylosing spondylitis in the south of SpainV Perez-Guijo, E Muñoz, A Escudero, et al.
Rheumatology (Oxford, England)|August 25, 2005
Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre studyE Collantes-Estevez, M C Muñoz-Villanueva, P Zarco, et al.
Annals of the Rheumatic Diseases|January 17, 2009
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)J Sieper, D van der Heijde, R Landewé, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Rheumatology|June 26, 1998
Osteonecrosis of the tibial plateauP Carpintero-Benitez, E Collantes-Estevez
The Journal of Rheumatology|June 1, 1996
Enthesopathy in leprosyP Carpintero-Benítez, C Logroño, E Collantes-Estevez
The Journal of Rheumatology|February 1, 1995
Assessment of 2 systems of spondyloarthropathy diagnostic and classification criteria (Amor and ESSG) by a Spanish multicenter study. European Spondyloarthropathy Study GroupE Collantes-Estevez, A Cisnal del Mazo, E Muñoz-Gomariz
Clinical and Experimental Rheumatology|January 1, 1993
Expression of complement receptors (CR1 and CR3) and Fc gamma RIII on polymorphonuclears from patients with spondylarthropathiesA Kahan, E Collantes-Estevez, M Barel, et al.
Clinical Rheumatology|March 1, 1990
Hyperuricemia-hyperlipemia association in the absence of obesity and alcohol abuseE Collantes Estevez, M Pineda Priego, J Añon Barbudo, et al.
Scandinavian Journal of Rheumatology|January 15, 2008
The cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in Spain. Comparison of clinical trial and clinical practice dataG Kobelt, P Sobocki, J Mulero, et al.
Annals of the Rheumatic Diseases|October 17, 2002
Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experienceJ Braun, J Sieper, M Breban, et al.
Joint Bone Spine|December 13, 2002
Distribution of HLA-DRB1 genes in patients with sporadic ankylosing spondylitis in the south of SpainV Perez-Guijo, E Muñoz, A Escudero, et al.
Rheumatology (Oxford, England)|August 25, 2005
Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre studyE Collantes-Estevez, M C Muñoz-Villanueva, P Zarco, et al.
Annals of the Rheumatic Diseases|January 17, 2009
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)J Sieper, D van der Heijde, R Landewé, et al.
Pageof 2